Live Breaking News & Updates on Vishala Patel

Stay updated with breaking news from Vishala patel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

When Does the PD-1 Inhibitor Come Before the Hedgehog Inhibitor for Neoadjuvant BCC/CSCC?

Experts discuss when to use the PD-1 inhibitor cemiplimab vs the hedgehog inhibitor vismodegib as neoadjuvant treatment in non-melanoma skin cancers. ....

United States , University Of California San Francisco , Vishala Patel , Rebeccai Hartman , Anne Lynns Chang , Michaelr Migden , Sarah Arron , Johnm Strasswimmer , Dermatology Associates Of The Palm Beaches , Department Of Dermatology , Peninsula Dermatology Medical Group In Burlingame , Harvard Medical School , Gw Cancer Center , Regeneron Pharmaceuticals Inc , University Of Texas Md Anderson Cancer Center , European Union , Treatment Strategies , Skin Cancer , Cutaneous Oncology , Dermatologic Surgery , George Washington University School , Health Sciences , With Cemiplimab , Hedgehog Inhibition With Vismodegib , Mohs Surgeon , Peninsula Dermatology Medical Group ,

Palvella Therapeutics Announces Planned Pivotal Phase 3 Study Design of QTORIN™ 3.9% Rapamycin ...

QTORIN™ rapamycin has potential to become first approved therapy and standard of care for Microcystic Lymphatic Malformations in U.S.; significant commercial opportunity based on an estimated more than 30,000 individuals ....

Marcy Nanus , Microcystic Lms , Wesleyh Kaupinen , Wes Kaupinen , Joycem Teng , Vishala Patel , European Medicines Agency , Trilon Advisors , Stanford University School Of Medicine , Gorlin Syndrome Alliance , Palvella Therapeutics Inc , Microcystic Lymphatic Malformations , Microcystic Lymphatic , Clinician Global Impression , Basal Cell Carcinomas , Gorlin Syndrome , Basal Cell Carcinoma , Clinically Suspicious , Biopsy Confirmed Basal Cell Carcinoma , Palvella Therapeutics , Chief Executive , Biopsy Confirmed , Global Impression , Lymphatic Malformations , Stanford University School , Orphan Drug ,

Why Dermatologists Should Support Artificial Intelligence

"AI is meant to be an enhancement strategy, a support tool to improve our diagnostic abilities," says Vishal Patel, MD. ....

United States , Warrenh Chan , Hensin Tsao , Vishala Patel , George Washington University Cancer Center , Convolutional Neural Network , Pigmented Lesion Assay , Gene Expression Profile Test , Malignant Melanoma , Skin Cancer , Alignant Skin Neoplasm , Cutaneous Melanoma , Artificial Intelligence , A I , Healthcare And Medical Technology , Ealth And Medical Tech , Ealth And Med Tech , Ealth And Medical Technology , Clinical Guidelines ,

Survey: Dermatologists Supportive of Artificial Intelligence

Survey questions included how respondents would use AI to help their patients, and how they felt about non-dermatologists using AI to detect skin lesions. ....

United States , Vishala Patel , George Washington University Cancer Center , Orlando Dermatology , Surgical Conference , Malignant Melanoma , Skin Cancer , Alignant Skin Neoplasm , Skin Lesion , Artificial Intelligence , A I , Healthcare And Medical Technology , Ealth And Medical Tech , Ealth And Med Tech , Ealth And Medical Technology ,